Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 8, 2022 | Post-IPO Debt | $45M | — | — | — | Detail |
Jul 30, 2021 | IPO | $73.30M | — | — | — | Detail |
Dec 10, 2020 | Series E | $69M | — | — | — | Detail |
Feb 7, 2018 | Series Unknown | $53M | 9 | Bossa Ventures , Cathay Venture , GeneScience Pharmaceuticals , Shire | — | Detail |
Sep 9, 2017 | Series D | $39M | 3 | GV | — | Detail |
May 26, 2015 | Series C | $37.10M | 9 | — | — | Detail |
Jul 28, 2013 | Series B | $9.40M | 3 | GV | — | Detail |
Jun 13, 2012 | Series A | $4M | 1 | Incube Ventures | — | Detail |